• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Aspire Biopharma Holdings, Inc. - Warrant (NQ:ASBPW)

    0.0150 -0.0027 (-15.25%)
    Streaming Delayed Price Updated: 9:30 AM EDT, Mar 17, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 30,000
    Open 0.0150
    Bid (Size) 0.0178 (100)
    Ask (Size) 0.0209 (100)
    Prev. Close 0.0177
    Today's Range 0.0150 - 0.0150
    52wk Range 0.0100 - 0.0899
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026
    Via ACCESS Newswire

    Performance

    YTD
    -19.4%
    -19.4%
    1 Month
    -25.7%
    -25.7%
    3 Month
    -50.0%
    -50.0%
    6 Month
    -62.2%
    -62.2%
    1 Year
    -78.3%
    -78.3%

    More News

    Read More
    News headline image
    Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma's Buzz Bomb Caffeine Company Names ChicExecs as Public Relations Agency of Record
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Announces the Appointment of New Member to Its Board of Directors
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Ondansetron (Generic Zofran(R))
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to Meet Nasdaq Requirements
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma's Unveils Bold New Era for BUZZ BOMB(TM) Caffeine with Dynamic Website and Packaging Redesign
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Formulation of Alprazolam - Generic Xanax(R) - for Rapid Anxiety Relief
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Announces Reverse Stock Split
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA)
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Welcomes Elite Ultra-Runner Ashley Paulson as Global Brand Ambassador for BUZZ BOMB(R) Caffeine
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Provides Q3 2025 Business Update
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)
    Via ACCESS Newswire
    News headline image
    Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin
    Via ACCESS Newswire

    Frequently Asked Questions

    Is Aspire Biopharma Holdings, Inc. - Warrant publicly traded?
    Yes, Aspire Biopharma Holdings, Inc. - Warrant is publicly traded.
    What exchange does Aspire Biopharma Holdings, Inc. - Warrant trade on?
    Aspire Biopharma Holdings, Inc. - Warrant trades on the Nasdaq Stock Market
    What is the ticker symbol for Aspire Biopharma Holdings, Inc. - Warrant?
    The ticker symbol for Aspire Biopharma Holdings, Inc. - Warrant is ASBPW on the Nasdaq Stock Market
    What is the current price of Aspire Biopharma Holdings, Inc. - Warrant?
    The current price of Aspire Biopharma Holdings, Inc. - Warrant is 0.0150
    When was Aspire Biopharma Holdings, Inc. - Warrant last traded?
    The last trade of Aspire Biopharma Holdings, Inc. - Warrant was at 03/17/26 09:30 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.